Medical Group Management Association (MGMA)

The Medical Group Management Association (MGMA) serves members, customers, and the healthcare community as a trusted partner by delivering insights, solutions, and advocacy to achieve medical practice excellence. MGMA advocates for priority issues affecting medical groups in Washington, D.C. and assists members in meeting the challenges posed by today’s rapidly evolving healthcare environment. 

MGMA's Anders Gilberg discusses concerns on Medicare physician fee schedule

MGMA concerned by 2025 Medicare Physician Fee Schedule

The Medical Group Management Association (MGMA) Senior Vice of Government Affairs, Anders Gilberg, explains MGMA’s 28-page letter to CMS on issues with the proposed 2025 Medicare Physician Fee Schedule.
 

Thumbnail

Industry groups applaud bill connecting Medicare payments to inflation

Healthcare groups are applauding a bill in the House of Representatives that would ensure Medicare payments are tied to inflation.

Healthcare industry reacts to PHE ending in May

MGMA and AHA discuss how the end of the PHE will impact healthcare stakeholders.

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association. These include staving off the large, planned 2023 Medicare reimbursement cuts, fighting for continuation of reimbursements for telehealth, and revamping prior authorizations.

VIDEO: Top priorities for the Medical Group Management Association in 2022

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

files paperwork work load

Healthcare groups react to prior authorization proposed rule

Healthcare groups are largely excited by a new proposed rule from the Centers for Medicare and Medicaid Services (CMS) that aims to streamline prior authorization and reduce burden on healthcare providers.

Providers face ‘ominous reality’ of payment cuts as CMS finalizes 2023 Physician Fee Schedule

Physicians are now bracing for payment cuts after the Centers for Medicare and Medicaid Services (CMS) published its final rule for the 2023 Physician Fee Schedule.

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association. These include staving off the large, planned 2023 Medicare reimbursement cuts, fighting for continuation of reimbursements for telehealth, and revamping prior authorizations.

VIDEO: MGMA explains why the COVID-19 public health emergency extension is critical

Claire Ernst, director of government affairs for the Medical Group Management Association, talked to us about why extending the federal COVID-19 health emergency was so important for healthcare providers.

Thumbnail

Physician group asks for extension on surprise billing regulations

While MGMA recognized that the No Surprises Act “established critical patient protections against balance billing and created new cost transparency tools to help patients,” the association argued the new requirements for 2022 also carried “ significant additional administrative burdens for group practices.”

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.